LivaNova PLC

LIVN Net selling

CIK 0001639691 #1466 in the set updated 17 Sep 2026

Bought (120 mo)

$268.53K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$52.36M

$94.46K on a plan · $6.34M straight out of an exercise

Sold at will

$45.92M

95 of 106 sales

Net

−$52.09M

−$45.65M against sales at will

By person

36 insiders · 114 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

EQUINOX TWO S.C.A.

10% owner

—

$35.14M (9)

−$35.14M

4,863,369

8.83%

$379.39M

−10.6%

Moore Daniel Jeffrey

Director

—

$7.58M (42)

−$7.58M

27,534

0.0500%

$2.15M

−58.9%

McDonald Damien

CEO

—

$3.87M (15)

−$3.87M

114,067

0.2070%

$8.90M

—

WISE DAVID S

Chief Administrative Officer

—

$1.69M (11)

−$1.69M

27,929

0.0507%

$2.18M

−18.3%

Bianchi Francesco

Director

—

$1.01M (8)

−$1.01M

4,434

0.0080%

$345.89K

+626.9%

Novak Alfred J

Director

$46.71K (1)

$825.73K (8)

−$779.01K

12,617

0.0229%

$984.24K

−7.5%

Dolci Marco

President CP

—

$686.33K (2) scheduled

−$686.33K

7,708

0.0140%

$601.29K

+1,155%

MORRISON HUGH M

Director

—

$553.38K (4)

−$553.38K

5,266

0.0096%

$410.80K

−9.2%

Huston Thad Allen

Chief Financial Officer

—

$312.98K (2)

−$312.98K

27,005

0.0490%

$2.11M

—

Manko Douglas John

Chief Accounting Officer

—

$250.28K (1) scheduled

−$250.28K

3,277

0.0059%

$255.64K

—

Tezel Ahmet

Chief Innovation Officer

—

$207.94K (1) scheduled

−$207.94K

6,090

0.0111%

$475.08K

—

Story Brooke

Director

—

$200.76K (2)

−$200.76K

7,488

0.0136%

$584.13K

—

KOZY WILLIAM A

Director

$163.23K (2)

—

+$163.23K

37,566

0.0682%

$2.93M

+6,355%

O'Kane Sharon

Director

$58.58K (1)

—

+$58.58K

11,304

0.0205%

$881.82K

—

Simpson Alistair

General Manager, CS

—

$40.55K (1)

−$40.55K

1,945

0.0035%

$151.73K

+133.8%

BALLESTER ANDRE MICHEL

CEO

—

—

—

93,822

0.1703%

$7.32M

+15.9%

Andrle Edward

General Manager, NM

—

—

—

64,502

0.1171%

$5.03M

+135.7%

Shvartsburg Alex

Chief Financial Officer

—

—

—

44,647

0.0810%

$3.48M

+2,805%

ROSENTHAL ARTHUR L

Director

—

—

—

23,606

0.0428%

$1.84M

+48.7%

Bolton Stephanie

President, Global Epilepsy

—

—

—

22,189

0.0403%

$1.73M

+306.3%

Enxing Seng Stacy

Director

—

—

—

15,307

0.0278%

$1.19M

+2,314%

Makatsaria Vladimir

Chief Executive Officer

—

—

—

14,167

0.0257%

$1.11M

—

Hebbelinck Trui

Chief Human Resources Officer

—

—

—

13,779

0.0250%

$1.07M

—

SCHERMERHORN TODD C

Director

—

—

—

12,619

0.0229%

$984.40K

—

Saia Andrea Lynn

Director

—

—

—

10,799

0.0196%

$842.42K

+1,656%

Poletti Franco

President, Cardiopulmonary

—

—

—

10,755

0.0195%

$838.99K

+61.3%

WILVER PETER M

Director

—

—

—

10,294

0.0187%

$803.03K

—

Skeffington Keyna Pidcock

General Counsel

—

—

—

8,090

0.0147%

$631.09K

—

Barry James Christopher

Director

—

—

—

7,918

0.0144%

$617.68K

—

Hutchinson Michael Damon

SVP, CLO and Company Secretary

—

—

—

6,798

0.0123%

$530.31K

—

PODLOGAR SUSAN M

Director

—

—

—

5,642

0.0102%

$440.13K

—

Kozmina Natalia

Chief Human Resources Officer

—

—

—

5,015

0.0091%

$391.22K

—

Khoury Roy

President, International

—

—

—

4,695

0.0085%

$366.25K

+315.9%

Sehgal Vivid

CFO

—

—

—

2,761

0.0050%

$215.38K

—

Zurbay Donald

Director

—

—

—

2,252

0.0041%

$175.68K

—

Gianotti Stefano

Director

—

—

—

1,830

0.0033%

$142.76K

—

Individual transactions

1

Insider

Date

Role

Action

Shares

Price

Amount

McDonald Damien

30 Mar 2023

CEO

Sold on a plan

2,220

$42.55

$94.46K

Show all 114 transactions →

What was left out

Form 4 filings counted 419

Amendments (4/A) skipped 13

Filings about a different issuer 0

Unreadable filings 0

Joint filings 2

Sales on a Rule 10b5-1 plan 1

Sales straight out of an exercise 10

Sales at will 95

Transactions with no price 0

Shares from compensation/vesting 1,339,486

Sales filed before the plan box existed 87

History held since 8 Sep 2016